Wells Fargo’s Dimension Therapeutics, Inc DMTX Stock Holding History

Wells Fargo’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,592	Closed	-$76K	–	6809
2017 Q3	$76K	Sell	12,592 -42,633	-77%	-$111K	﹤0.01%	5333
2017 Q2	$80K	Buy	55,225 +8,237	+18%	+$11.2K	﹤0.01%	5264
2017 Q1	$82K	Buy	46,988 +25,676	+120%	+$68.1K	﹤0.01%	5276
2016 Q4	$93K	Buy	21,312 +11,663	+121%	+$62.1K	﹤0.01%	5188
2016 Q3	$77K	Buy	+9,649	New	+$69.8K	﹤0.01%	5070
2016 Q2	–	Sell	-1,020	Closed	-$8K	–	6731
2016 Q1	$8K	Buy	1,020 +1,000	+5,000%	+$7.88K	﹤0.01%	5793
2015 Q4	$0	Buy	+20	New	+$253	﹤0.01%	6786

Wells Fargo's DMTX Position: Q4 2017 in Review

Wells Fargo sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 12,592 shares — an estimated $76K sold.

Wells Fargo first reported a position in DMTX in Q4 2015 and held it in 7 quarters. The position peaked at $93K in Q4 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Wells Fargo reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Wells Fargo sold 12,592 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $76K.
Wells Fargo first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 7 quarters.
Wells Fargo's Dimension Therapeutics, Inc position peaked at $93K in Q4 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.